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1. Introduction 
A relevant number of peripheral nerve injuries can only be dealt through reconstructive 
surgical procedures. Despite continuous refinement of microsurgery techniques, peripheral 
nerve repair still stands as one of the most challenging tasks in neurosurgery. Particularly 
problematic is the fact that despite the good regenerative ability of peripheral nerves and 
successful surgical nerve repair functional recovery is most often disappointing in these 
patients (Lundborg, 2002). While direct nerve repair should be the procedure of choice 
whenever tension-free suturing is possible, in many cases there is a significant loss of nerve 
tissue and resulting nerve gap. In these cases a nerve graft might be necessary for adequate 
nerve repair (Lundborg, 2002). Nerve grafting, however have some disadvantages, the most 
prominent being donor site morbidity that may lead to a secondary sensory deficit and 
occasionally neuroma and pain. In addition, non-matching donor and recipient nerve 
diameters often occur, which might be at the basis of poor functional recovery (May, 1983). 
Entubulation offers advantages over autographs, including the potential to manipulate the 
regeneration environment within the tube-guide (Fields et al., 1989). Consequently, 
guidance of regenerating axons is not only achieved by a mechanical effect but also by a 
chemical effect (such as accumulation of neurotrophic factors) (Meek & Coert, 2002). Nerve 
guides can be made of biological or synthetic materials and, among the latter, both non-
absorbable (e.g. silicon) and biodegradable tubes have been used (Schmidt & Leach, 2003). 
Biodegradable nerve guides must be preferred since no foreign body material will be left in 
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the host after the device has fulfilled its task. Four types of nerve guides attracted particular 
attention of our research group: those made of PLGA (Luis et al., 2007b; Luis et al., 2008) 
and poly-ε-caprolactone (Luis et al., 2008; Varejao et al., 2003a), collagen (Amado et al., 2010) 
and chitosan (Amado et al., 2008). In particular, chitosan has recently attracted particular 
attention because of its biocompatibility, biodegradability, low toxicity, low cost, 
enhancement of wound-healing and antibacterial effects and its potential usefulness in 
nerve regeneration have been demonstrated both in vitro and in vivo (Amado et al., 2010;  
Shirosaki et al., 2005; Simoes et al., 2010). Chitosan is a partially deacetylated polymer of 
acetyl glucosamine obtained after the alkaline deacetylation of chitin (Senel & McClure, 
2004). While chitosan matrices have low mechanical strength under physiological conditions 
and are unable to maintain a predefined shape after transplantation, their mechanical 
properties can be improved by modification with a silane agent, namely γ-
glycidoxypropyltrimethoxysilane (GPTMS), one of the silane-coupling agents which has 
epoxy and methoxysilane groups. The epoxy group reacts with the amino groups of 
chitosan molecules, while the methoxysilane groups are hydrolyzed and form silanol 
groups, and the silanol groups are subjected to the construction of a siloxane network due to 
the condensation. Thus, the mechanical strength of chitosan can be improved by the cross-
linking between chitosan, GPTMS and siloxane network. We have previously obtained by 
adding GPTMS, chitosan type III membranes (hybrid chitosan membranes) which have 
about 110 µm pores and about 90% of porosity, due to the employment of freeze-drying 
technique, and which were successful in improving sciatic nerve regeneration after 
axonotmesis (Amado et al., 2008). Wettability of the material surfaces is one of the key 
factors for protein adsorption, cell attachment and migration (Amado et al., 2008). The 
addition of GPTMS improves the wettability of chitosan surfaces, and therefore chitosan 
type III membranes are more hydrophilic than types of chitosan membranes (Shirosaki et al., 
2005). In addition, chitosan type III was developed to be more porous, with a larger surface 
to volume ratio, and to preserve mechanical strength and ability to adapt to different 
shapes. Significant differences in water uptake between commonly used chitosan and our 
hybrid chitosan type III were previously reported and it has been shown that they retain 
about two times as much biological fluid (Tateishi et al., 2002). The Neurolac® and the 
PLGA90:10 tube-guides guides show several different physical-chemical properties, namely 
Neurolac® is stiffer than PLGA due to structural reinforcement of the ester bonds and does 
not degrade so quickly. The biodegradation rate of PLGA tubes is estimated to be around 3 
months while that complete resorption of Neurolac® is estimated to be of 16 months 
approximately (Geuna et al., 2009; Luis et al., 2007b; Luis et al., 2008). The degradation 
products of Neurolac® are less acidic, which may cause less damage to the surrounding 
tissue, and they are transparent so that the correct positioning of the nerve stumps may be 
confirmed after suturing. On the other hand, the biodegradable non woven structure of 
PLGA tubes may offer some advantages in terms of microporosity which may enhance 
nerve repair (Luis et al., 2007b; Luis et al., 2008). In vitro studies have shown that the four 
types of tube-guides, namely, the PLGA, the collagen, the hybrid chitosan and the 
Neurolac® are biocompatible to nerve cells and can facilitate nerve cell attachment, 
differentiation and growth (Amado et al., 2008; Luis et al., 2007b; Luis et al., 2008; Luis et al., 
2008; Wang et al., 2008). Our research group tested the PLGA90:10, the hybrid chitosan type 
III and the collagen tube-guides covered with the neural cells in vitro differentiated for 48 
hours in the presence of DMSO (Amado et al., 2010; Amado et al., 2008; Luis et al., 2008; 
Simoes et al., 2010). The Neurolac® tubes were not tested with the cellular system, since the 
www.intechopen.com
 
Cellular Systems and Biomaterials for Nerve Regeneration in Neurotmesis Injuries 
 
417 
cell adherence was more difficult to obtain and imply the previous covering with poli-l-
lysine (Amado et al., 2010; Amado et al., 2008; Luis et al., 2008; Simoes et al., 2010). It is 
expected that tissue engineering associating these biomaterials to cellular systems, capable 
of differentiating into neuron-like cells, may improve peripheral nerve regeneration, in 
terms of motor, sensory and histomorphometric parameters. The N1E-115 cells derived from 
mouse neuroblastomas (Amano et al., 1972) can in vitro differentiate into neural-cells 
(Amano et al., 1972; Rodrigues et al., 2005) and were used as a cellular model for stem cells. 
In addition, mesenchymal cells isolated from the Wharton’s jelly of the umbilical cord, were 
used by our research group (data not published yet). Stem cells can be loosely classified into 
3 broad categories based on their time of isolation during ontogenesis: embryonic, fetal and 
adult (Marcus & Woodbury, 2008). Recent years have witnessed an explosion in the number 
of adult stem cells populations isolated and characterized. While still multipotent, adult 
stem cells have long been considered restricted, giving rise only to progeny of their resident 
tissues. Recently, and currently controversial studies have challenged this dogma, 
suggesting that adult stem cells may be far more plastic than previously appreciated 
(Marcus & Woodbury, 2008). Extra-embryonic tissues as stem cell reservoirs offer many 
advantages over both embryonic and adult stem cell sources. Extra-embryonic tissues, 
collectively known as the afterbirth, are routinely discarded at parturition, so little ethical 
controversy attends the harvest of the resident stem cell populations. Most significantly, the 
comparatively large volume of extra-embryonic tissues and ease of physical manipulation 
theoretically increases the number of stem cells that can be isolated (Marcus & Woodbury, 
2008). The umbilical cord contains two arteries and one vein protected by a proteoglycan 
rich connective tissue called Wharton’s jelly. Within the abundant extracellular matrix of 
Wharton’s jelly resides a recently described stem cell population called Umbilical Cord 
Matrix Stem Cells. It can be isolated around 400,000 cells per umbilical cord, which is 
significantly greater than the number of MSCs that can be routinely isolated from adult bone 
marrow. In vitro the Wharton’s jelly MSCs cells are capable of differentiation to multiple 
mesoderm cell types including skeletal muscle and neurons (Fu et al., 2006; Wang et al., 
2004). Human MSCs (HMSCs) isolated from Wharton’s jelly of the umbilical cord can be 
easily and ethically obtained and processed compared with embryonic or bone marrow 
stem cells. These cells may be a valuable source in the repair of the peripheral nerve system. 
HMSCs from Wharton’s jelly of the umbilical cord possess stem cell properties (Yang et al., 
2008) and it was previously demonstrated that HMSCs could be induced to differentiate into 
neuron-like cells (Fu et al., 2006). The transplanted cells were able to promote local blood 
vessel formation and expression of the neurotrophic factors, brain-derived neurotrophic 
factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) (Wang et al., 2004). 
Therefore, the purpose to cover the PLGA 90:10, hybrid chitosan, and collagen tube-guides 
used in reconstructed nerves after neurotmesis with a cellular system differentiated in vitro 
into neuronal cells, was to produce locally neurotrophic factors in a physiological 
concentration. The role of neurotrophic factors in neural regeneration has been the focus of 
extensive research (Amado et al., 2010; Hu et al., 1997). The influence of these factors in 
neural development, survival, outgrowth, and branching has been explored on various 
levels, from the molecular level to the macroscopic tissue responses. Neurotrophic factors 
promote a variety of neural responses, like the survival and outgrowth of the motor and 
sensory nerve fibers, and are implicated in spinal cord and peripheral nerve regeneration 
(Geuna et al., 2009; Johnson et al., 2008). However, in vivo, the efficacy of neurotrophic 
factors might vary greatly due to the method used for their delivering and it is thus 
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important to deliver them near the regenerating site, in the physiologic concentrations. In 
this view, association of a cellular system producing neurotrophic factors to biodegradable 
membranes may greatly improve the nerve regeneration in neurotmesis (Geuna et al., 2009). 
N1E-115 cell line established from a mouse neuroblastoma (Kerns et al., 1991), might be a 
useful cellular system to locally produce and deliver these neurotrophic factors (Geuna et 
al., 2001). In vitro, the N1E-115 cells undergo neuronal differentiation in response to 
dimethylsulfoxide (DMSO), adenosine 3’, 5’- cyclic monophosphate (cAMP), or serum 
withdrawal (Koka & Hadlock, 2001; Luis et al., 2007b; Luis et al., 2008; Luis et al., 2008). 
Upon induction of differentiation, proliferation of N1E-115 cells ceases, extensive neurite 
outgrowth is observed and the membranes become highly excitable (Koka & Hadlock, 2001; 
Luis et al., 2007b; Luis et al., 2008). The ideal interval period of 48 hours of differentiation 
was determined by measurement of the intracellular calcium concentration ([Ca2+]i), when 
the N1E-115 cells presented already the morphological characteristics of neuronal cells but 
at a time, cell death due to increased [Ca2+]i was not still occurring (Rodrigues et al., 2005). 
2. Biomaterial for tube-guides fabrication  
The tube-guides or scaffold of tissue engineered nerve grafts serve in neurotmesis injuries to 
direct axons sprouting from the proximal to the distal stump, to maintain adequate 
mechanical support for the regenerating nerve fibers. Yet, they provide a conduit channel 
for the diffusion of neurotrophic and neurotropic factors secreted in the regeneration local 
and provide a conduit wall for the exchange of nutrients and waste products with the 
surrounding media, limiting the infiltration of fibrous scar tissue that hinders axonal 
regeneration (Johnson & Soucacos, 2008;). The neural scaffolds should be easy to be 
fashioned in different lengths and diameters, to be sterilized and implanted using 
microsurgical techniques. The neural scaffold has to satisfy many biological and 
physicochemical requirements like biocompatibility, biodegradability, permeability to ions, 
metabolites and for the revascularization of the regenerated nerve, biomechanical properties 
and surface properties that modulate the cellular system adhesion (Huang & Huang, 2006). 
A wide variety of biomaterials has been attempted which are of either natural or synthetic 
origin. 
2.1 Natural biomaterials 
The natural biomaterials are known by stimulating cell adhesion, migration, growth and 
proliferation. The natural biomaterials have also a very good biocompatibility and less toxic 
effects. Our research group has tested the collagen and the chitosan. 
Collagen, laminin and fibronectin play an important role in the development and growth of 
axons (Grimpe & Silver, 2002). So, these components have become very important 
candidates for neural scaffolds, these materials can also serve as delivery vehicles for 
support cells, growth factors and drugs. For example, silicone tubes filled with laminin, 
fibronectin, and collagen led to a better regeneration over a 10 mm rat sciatic nerve gap 
compared to empty silicone controls (Chen et al., 2007). Collagen filaments have also been 
used to guide regenerating axons across 20–30 mm defects in rats (Itoh et al., 2003; Yoshii & 
Oka, 2001). Further studies have shown that oriented fibers of collagen within gels, aligned 
using magnetic fields, provide an improved template for neurite extension compared to 
randomly oriented collagen fibers (Ceballos et al., 1999). Finally, rates of regeneration 
comparable to those using a nerve autograft have been achieved using collagen tubes 
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containing a porous collagen-glycosaminoglycan matrix (Archibald et al., 1995; Chamberlain 
et al., 2000). In our studies we have used equine collagen type III membrane (GentaFleece®; 
Baxter, Nuremberg, Germany) in axonotmesis and neurotmesis lesion of the rat sciatic nerve 
with very promising results (Amado et al., 2010; Luis et al., 2008). 
Chitin is the second most abundant polysaccharide found in nature next to cellulose. It is a 
biopolymer of N-acetyl-D-glucosamine monomeric units and it has been used in a wide 
range of biomedical devices. Chitosan is a copolymer of D-glucosamine and N-acetyl-D-
glucosamine and it has a very similar molecular structure with lamin, fibronectin and 
collagen. So, the chitosan has favorable biological properties for the nerve regeneration and 
it is easier to process than the chitin. Chitosan is quite fragile in its dry form, so, it has to 
undergo chemical cross-linking or to be used with other biomaterials before scaffold 
fabrication. The chitosan (high molecular weight, Aldrich®, USA) tested by our research 
group was dissolved in 0.25M acetic acid aqueous solution to a concentration of 2% (w/v). 
To obtain type III membranes, GPTMS (Aldrich®, USA) was also added to the chitosan 
solution and stirred at room temperature for 1h. The drying process for type III chitosan 
membrane was as follows: the solutions were frozen for 24h at -20°C and then transferred to 
the freeze-dryer, where they were left 12h to complete dryness. The chitosan type III 
membranes were soaked in 0.25N sodium hydroxide aqueous solution to neutralize 
remaining acetic acid, washed well with distilled water, and freeze dried (Amado et al., 
2008). All membranes used in vivo testing, were sterilized with ethylene oxide gas, 
considered by some authors the most suitable method of sterilization for chitosan 
membranes (Marreco et al., 2004). Prior to their use in vivo, membranes were kept 1 week at 
room temperature to clear any ethylene oxide gas remnants (Amado et al., 2008; Simoes et 
al., 2010) (see Fig.1). 
 
 
Fig. 1. SEM microstructure of chitosan membranes. Type II chitosan membrane (A). Type III 
chitosan membrane, showing a more porous microstructure, when compared to type II 
chitosan membrane (B) (Amado et al., 2008). 
2.2 Synthetic biomaterials 
The synthetic biopolymers constitute a group of promising biomaterials for the fabrication 
of neural tube-guides. However, the biocompatibility of some synthetic materials can be low 
since the difficulty of cell adhesion and survival can be a negative issue. Historically, non 
degradable synthetic materials were tested before the degradable ones. For instance, the 
silicone has been tested for peripheral nerve repair since 1960. Although it is not degradable 
in the body and it is impermeable to large molecules, the silicone tube-guide was an 
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important model system for studying nerve regeneration. It was also applied in several 
clinical trials to bridge short nerve gaps with some success (Gu et al., 2011). The use of non-
degradable tube-guides implies a second surgery time, which has clear disadvantages for 
the patient. In order to overcome the disadvantages associated with non-degradable 
materials, research has been focused in biodegradable synthetic biomaterials that should 
degrade within a reasonable time span. The degradation products absorbed should not be 
toxic or induce a foreign body reaction. Moreover, the physiochemical and biological 
properties of biodegradable synthetic materials can be tailored to match different 
application requirements, like to entrap some molecules or serve as a support for a cellular 
system. Aliphatic polyesters represent a class of the common degradable synthetic 
polymers, among which poly(L-lactic acid) (PLLA) (Wang et al., 2009), polyglycolic acid 
(PGA) (Waitayawinyu et al., 2007), polycaprolactone (PCL) (Mligiliche et al., 2003) and their 
copolymers, including poly(lactic-ε-caprolactone (Neurolac®) (Den Dunnen et al., 1998; Luis 
et al., 2007b) and poly(L-lactic-co-glycolic acid (PLGA) (Bini et al., 2004; Luis et al., 2007b; 
Luis et al., 2008). Among synthetic biodegradable tubes, two types attracted particular 
attention: those made of PLGA and those made of Poly (DL-lactide-ε-caprolactone) 
copolyester (Neurolac®) (see Fig.2). 
 
 
Fig. 2. PLGA 90:10 (A) and poly (DL-lactide-e-caprolactona) copolyester (Neurolac®) tube-
guides (B) (Luis et al., 2007b). 
These two types of nerve guides showed several different physical-chemical properties. The 
Poly (DL-lactide-ε-caprolactone) tube-guides (Neurolac®), 16 mm long, internal diameter of 
2 mm and thickness wall of 1.5 mm, were purchased from Polyganics BV, Groningen, The 
Netherlands (Luis et al., 2007b; Luis et al., 2008). Poly (dl-lactide-co-glycolide) copolymers 
with ratio of 90PLA:10PLG were obtained from their cyclic dimers, dl-lactide and glycolide. 
Non-woven constructs were used to prepare tube-guides 16 mm long, internal diameter of 
2.0 mm and thickness wall of 1.5mm, to be applied in a 10-mm sciatic nerve gap. These fully 
synthetic non-woven materials are extremely flexible, biologically safe and are able to 
sustain the compressive forces due to body movement after implantation. They have also 
some degree of porosity to allow for influx of low molecular nutrients required for nerve 
regeneration. The non-woven structure allowed the tube-guide to hold suture without 
difficulties, however greater care had to be taken in order to ensure its integrity. These tube-
guides of PLGA are expected to degrade to lactic and glycolic acids through hydrolysis of 
the ester bonds (Luis et al., 2007b; Luis et al., 2008).  
The polyvinyl alcohol hydrogel (PVA) tube-guides are now starting to be tested by our 
research groups. Previous studies showed the PVA potential to several biomedical 
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applications (Grant et al., 2006). The PVA gathers a set of exceptional properties, based in a 
nanofibrilar 3D structure, namely its high biocompatibility: it practically does not induce 
any foreign body or inflammatory reaction; it has high capacity to absorb water, mechanical 
resistance, elasticity, mobility and suturability (Bichara et al., 2010). The PVA are prepared 
in a tubular form, with 16 mm long, an internal diameter of 2 mm and thickness wall of 1.5 
mm. These forms are prepared by a casting route to a mould that allows the final shape and 
thickness. Among the several methods described for the preparation of PVA material, the 
physical cross-linking of PVA by cyclic freezing and thawing is the one with better 
mechanical results (data not published by our research group). PVA from Aldrich (Mowiol 
10-98: Mw 61,000, 98.0-98.8 mol% hydrolysis) is used. The tube-guides are produced using a 
solution of 20%(m/v) of PVA submitted to 3 repetitions of a freeze/thaw cycle, using 8 
hours of freezing at –20.0°C and 4 hours of thawing at 22°C. However, several freeze/thaw 
cycling schemes must be tested to evaluate their effect on the final physical and mechanical 
properties, and choose the best one. The possible involvement of a final annealing step in 
the production process is being considered. This type of nerve guides can have unlimited 
availability in terms of diameters and lengths. 
3. Cellular systems 
The use of neural scaffolds alone to repair peripheral nerve defects have achieved variable 
success, but only small gap nerve repair (of 10 mm in rat sciatic nerve and of 30 mm in 
primate ulnar nerve) demonstrated evident functional and morphologic recovery (Amado et 
al., 2010; Gu et al., 2011; Hood et al., 2009; Luis et al., 2007b; Luis et al., 2008; Simoes et al., 
2010). When the length of nerve gaps are increased, neural scaffolds alone only permit the 
bridging between the stumps, but for an effective regeneration, supporting cells or growth 
factors should be incorporated. The cellular systems implanted into the injury nerve may 
produce growth factors or ECM molecules, or may modulate the inflammatory process, to 
improve nerve regeneration (Amado et al., 2010; Gu et al., 2011; Luis et al., 2007b; Luis et al., 
2008; Simoes et al., 2010). Schwann cells, mesenchymal stem cells, embryonic stem cells, 
marrow stromal cells are the most studied candidates of support cells among others. We 
focused our research in N1E-115 cell line in vitro differentiated (Amado et al., 2010; Luis et 
al., 2007b; Luis et al., 2008; Simoes et al., 2010) and in mesenchymal stem cells from 
Wharton’s jelly of the umbilical cord (data not published yet).  
To implant cultured cells (N1E-115 cells, MSCs, Schwann cells, and other cellular systems) 
into defective nerves (with axonotmesis and neurotmesis injuries), there are two main 
techniques. The cellular system may be directly injected to the neural scaffold which has 
been interposed between the proximal and distal nerve stumps or around the crush injury 
(in neurotmesis and axonotmesis injuries, respectively). In alternative, implant can also be 
achieved by pre-adding the cells to the neural scaffold via injection or co-culture (in most of 
the cellular systems, it is allowed to form a monolayer) and then the biomaterial with the 
cellular system is implanted in the injured nerve (Amado et al., 2010; Luis et al., 2008; Luis et 
al., 2008; Simoes et al., 2010). 
3.1 Cell culture of N1E-115 cells – a cellular model for stem cells transplantation 
The role of neurotrophic factors in neural regeneration has been the focus of extensive 
research in nerve regeneration (Schmidt & Leach, 2003). The influence of these factors in 
neural development, survival, outgrowth, and branching has been explored on various 
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levels, from molecular interactions to macroscopic tissue responses. One family of 
neurotrophic factors, the neurotrophins, has been heavily investigated in nerve regeneration 
studies, including the nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) (Lundborg et al., 1994). 
Neurotrophic factors promote a variety of neural responses: survival and outgrowth of the 
motor and sensory nerve fibers, spinal cord and peripheral nerve regeneration (Schmidt & 
Leach, 2003). However, in vivo responses to neurotrophic factors can vary due to the method 
of their delivering. Therefore, the development and use of highly controlled delivery devices 
are required for the study of these extremely complex systems. For that reason, N1E-115 cell 
line established from neuroblastoma, that undergo neuronal differentiation in response to 
dimethylsul-foxide (DMSO), adenosine 3’;5’-cyclic monophosphate (cAMP), or serum 
withdrawal (Amado et al., 2010; Rodrigues et al., 2005) was a cellular system tested in 
axonotmesis and neurotmesis lesions to locally produce and deliver these neurotrophic 
factors. Upon induction of differentiation, proliferation of N1E-115 cells ceases, extensive 
neurite outgrowth is observed and the membranes become highly excitable (Amado et al., 
2010; Rodrigues et al., 2005). During differentiation, cyclin-dependent kinase (cdk) activities 
decline and phosphorylation of the retinoblastoma gene product (pRb) is lost, leading to the 
appearance of a pRb-containing E2F DNA-binding complex. The molecular mechanism by 
which pRb inhibits cell proliferation is becoming increasingly clear. pRb inhibits the activity 
of proteins that function as inducers of DNA synthesis (Kranenburg et al., 1995). Ca2+ serves 
as an important intracellular signal for cellular processes such as growth and differentiation. 
Free calcium levels within neural cells control many essential neural functions including 
neurotransmitter release, membrane conductance, nerve fibber excitability, coupling 
between neuronal cells, and axonal transport. Although regulation of the intracellular Ca2+ 
concentration ([Ca2+]i) is important for normal cell functioning, its deregulation has been 
linked to cellular pathologies and cell death (Trump & Berezesky, 1995). Deregulation in 
[Ca2+]i can be toxic to cells and is involved in the triggering of events leading to excitotoxic 
cell death in neurons, through the activation of calpain, phospholipases and endonucleases 
(Smith & Hall, 1988). Because of the importance of [Ca2+]i in neuronal health and disease, a 
relatively simple cell model system, where [Ca2+]i regulation can be studied fairly easily, is 
desirable. We have tested a non-expensive and easy method to culture neural-like cell line 
capable of producing locally, nerve growth factors and of growing inside PLGA90:10, 
chitosan and collagen tubular/membrane nerve guides (Amado et al., 2010; Amado et al., 
2008; Luis et al., 2008; Luis et al., 2008; Simoes et al., 2010), in order to use them to promote 
nerve regeneration across a peripheral nerve gap. To correlate the neuronal cells’ ability to 
promote nerve regeneration across a gap, through their differentiation grade and survival 
capacity, the [Ca2+]i of non-differentiated and DMSO differentiated N1E-115 cells was 
determined by the epifluorescence technique using the Fura-2-AM probe (Tsien, 1989). The 
measurement of [Ca2+]i permitted to determine an ideal period of differentiation of 48 hours, 
when the N1E-115 cells presented already the morphological characteristics of neuronal cells 
and at the same time, the death process was not initiated by the [Ca2+]i modifications. This 
cellular system was used in axonotmesis and neurotmesis injuries associated to chitosan, 
equine collagen type III and PLGA membranes or tube-guides in order to improve the 
functional and morphologic recovery of the nerve (Amado et al., 2010; Gu et al., 2011; Luis et 
al., 2007b; Luis et al., 2008; Simoes et al., 2010).  
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3.2 Wharton’s jelly mesenchymal cells  
After peripheral nerve injury, many neurons die. Because neurons cannot be easily 
expanded in vitro, there is a wide difficulty in applying primary cultured neurons to nerve 
tissue engineering. Embryonic stem cells (ESCs) have a great potential to proliferate 
unlimitedly and differentiate into neural cells using several differentiation protocols (Gu et 
al., 2011). The differentiation of ESCs can be modulated by growth factors and retinoic acid 
(Gu et al., 2011). Extensive research has been focused on the implantation of these stem cells 
in Central Nervous System (CNS) disorders, but in Peripheral Nerve System (PNS) injuries 
only a few studies were published. Cui and co-workers, in 2008, implanted ESC-derived 
neural progenitor cells into a 10-nm sciatic nerve gap, resulting in substantial axonal 
regrowth and nerve repair (Cui et al., 2008). The implanted cells survived for 3 months and 
could differentiate into myelinating cells. The nerve stumps presented almost normal 
diameter with longitudinally oriented, densely packed Schwann cell-like arrangement. The 
regenerated nerves also showed recovery of the functional activity, determined by 
electrophysiological records (Cui et al., 2008). Although these promising results, the ESCs 
have serious ethical issues, especially when obtained by somatic nuclear transfer technique 
or from embryos produced for assisted medical reproduction. 
Recent years have witnessed a great expansion in the number of adult stem cell populations 
isolated and characterized. Adult stem cells have long been considered restricted, 
considering their multipotency. Many studies have challenged this dogma, suggesting that 
adult stem cells may be more plastic than previously appreciated (Beer et al., 2001). Extra-
embryonic tissues as stem cell reservoirs offer many advantages over embryonic and adult 
stem cell sources, and are routinely discarded at parturition. Little ethical controversy 
attends the harvest of the resident stem cell populations. Human umbilical cord (UC) 
consists of three tissue components including the (1) amniotic membrane, (2) stroma 
(namely, Wharton’s jelly), and (3) blood vessels (two arteries and one vein). The stroma is 
also further divided into three histological zones including the (1) subamniotic zone, (2) 
intervascular zone, and (3) perivascular zone (Can & Karahuseyinoglu, 2007). Wharton´s 
jelly (WJ) is a proteoglycan rich connective tissue of the UC. Within the abundant 
extracellular matrix of WJ resides a recently described stem cell population called UC Matrix 
Stem Cells. Can be isolated around 400,000 cells per UC, which is significantly greater than 
the number of MSCs that can be routinely isolated from adult bone marrow. Isolated MSCs 
express CD29 and CD54, consistent with a mesenchymal cell type, and can be propagated in 
culture for more than 80 population doublings (Marcus & Woodbury, 2008). In vitro the WJ 
MSCs cells are capable of differentiation to multiple mesodermal cell types. This cells have 
been successfully differentiated into various cell types including adipocytes 
(Karahuseyinoglu et al., 2008), chondrocytes (Baksh et al., 2007; Wang et al., 2004), 
osteocytes (Baksh et al., 2007; Conconi et al., 2006; Wang et al., 2004), cardiomyocytes 
(Kadivar et al., 2006; Wang et al., 2004), skeletal myocytes (Conconi et al., 2006), hepatocytes 
(Kadivar et al., 2006), insulin-producing cells (Wu et al., 2009) as well as neuron-like cells 
(Fu et al., 2006;  Weiss et al., 2006) (see Fig.3).  
Generation of clinically important dopaminergic neurons has been also reported by other 
groups (Fu et al., 2006; Wang et al., 2004). MSCs isolated from WJ may be a valuable cellular 
system to improve peripheral nerve regeneration, since they possess stem cell properties 
and are able to differentiate in vitro into neuron-like cells (Fu et al., 2006; Yang et al., 2008). 
The transplanted cells are able to promote local blood vessel formation and to locally 
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produce neurotrophic factors like BDNF and GDNF (Wang et al., 2004). Transformed MSCs 
are still viable 4 months after transplantation without the need for immunological 
suppression, suggesting them as good source for Regenerative Medicine (Fu et al., 2006). 
 
 
Fig. 3. Undifferentiated mesenchymal stem cells, from Wharton’s jelly, exhibiting a star-like 
shape with a flat morphology (A) and neural-like cells, differentiated after 96 hours with 
neurogenic medium, formation of typical neural-like multi-branches (B) (100X 
magnification). 
4. Microsurgical procedures 
Rodents, particularly the rat and the mouse, have become the most frequently utilized 
animal models for the study of peripheral nerve regeneration because of the widespread 
availability of these animals as well as the distribution of their nerve trunks which is similar 
to humans (Mackinnon et al., 1985; Rodriguez & Navarro, 2004). Although other nerve 
trunks, especially in the rat forelimb, are getting more and more used for experimental 
research (Papalia et al., 2006), the rat sciatic nerve is still the far more employed 
experimental model as it provides a nerve trunk with adequate length and space at the mid-
thigh for surgical manipulation and/or introduction of grafts or guides (Rodriguez & 
Navarro, 2004). Although sciatic nerve injuries themselves are rare in humans, this 
experimental model provides a very realistic testing bench for lesions involving 
plurifascicular mixed nerves with axons of different size and type competing to reach and 
reinnervate distal targets (Mackinnon et al., 1985). Common types of experimentally 
induced injuries include focal crush or freeze injury that causes axonal interruption but 
preserves the connective sheaths (axonotmesis), complete transection disrupting the whole 
nerve trunk (neurotmesis) and resection of a nerve segment inducing a gap of certain length. 
For these reasons our experimental work, concerning the in vivo testing of neurotmesis 
injury regeneration, was based on the use of Sasco Sprague-Dawley rat sciatic nerve. 
Usually, the surgeries are performed under an M-650 operating microscope (Leica 
Microsystems, Wetzlar, Germany). Under deep anaesthesia (ketamine 9 mg/100 g; xylazine 
1.25 mg/100 g, atropine 0.025 mg/100 body weight, intramuscular), the right sciatic nerve is 
exposed through a skin incision extending from the greater trochanter to the distal mid-half 
followed by a muscle splitting incision. After nerve mobilisation, a transection injury is 
performed (neurotmesis) using straight microsurgical scissors, at a level as low as possible, 
in general, immediately above the terminal nerve ramification. The proximal and distal 
nerve stumps are inserted 3 mm into the tube-guide (not covered or covered with cells) and 
BA 
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held in place, maintaining a nerve gap of 10mm, with two epineurial sutures using 7/0 
monofilament nylon. For neurotmesis without gap, the nerve is reconstructed with an end-
to-end suture, with two epineural sutures using de 7/0 monofilament nylon. Finally the skin 
and subcutaneous tissues are closed with a simple-interrupted suture of a non-absorbable 
filament (Synthofil®, Ethicon). An antibiotic (enrofloxacin, Alsir® 2.5 %, 5 mg / kg b.w., 
subcutaneously) is always administered to prevent any infections. To prevent autotomy a 
deterrent substance must be applied to rats’ right foot (Kerns et al., 1991; Sporel-Ozakat et 
al., 1991). All procedures must be performed accordance with the European Communities 
Council Directive of November 1986 (86/609/EEC). 
5. Functional evaluation  
Our studies of sciatic nerve regeneration after neurotmesis include a post-surgery follow-up 
period of 20 weeks based on the assumption that, by the end of this time, functional and 
morphological recovery are complete (Amado et al., 2010; Luis et al., 2007b; Luis et al., 2008; 
Simoes et al., 2010). Although both morphological and functional data have been used to 
assess neural regeneration after induced neurotmesis and axonotmesis  injuries, the 
correlation between these two types of assessment is usually poor (Dellon & Mackinnon, 
1989; Shen & Zhu, 1995). Classical and newly developed methods of assessing nerve 
recovery, including histomorphometry, retrograde transport of horseradish peroxidase and 
retrograde fluorescent labelling (Mackinnon et al., 1985; Mackinnon SE, 1988) do not 
necessarily predict the reestablishment of motor and sensory functions (de Medinaceli et al., 
1982; Shen & Zhu, 1995). Although such techniques are useful in studying the nerve 
regeneration process, they generally fail in assessing functional recovery (Shen & Zhu, 
1995). In this sense, research on peripheral nerve injury needs to combine both functional 
and morphological assessment. The use of biomechanical techniques and rat’s gait 
kinematic evaluation is a progress in documenting functional recovery (Varejao et al., 
2003b). Indeed, the use of biomechanical parameters has given valuable insight into the 
effects of the sciatic denervation/reinnervation, and thus represents an integration of the 
neural control acting on the ankle and foot muscles (Varejao et al., 2003b; Varejao et al., 
2002). 
5.1 Evaluation of motor performance (EPT) and nociceptive function (WRL)  
Motor performance and nociceptive function were evaluated by measuring extensor 
postural thrust (EPT) and withdrawal reflex latency (WRL), respectively. The animals are 
tested pre-operatively (week-0), at weeks 1, 2, and every two weeks thereafter until week-20. 
The EPT was originally proposed by Thalhammer and collaborators, (Thalhammer et al., 
1995) as a part of the neurological recovery evaluation in the rat after sciatic nerve injury. 
For this test, the entire body of the rat, excepting the hind-limbs, is wrapped in a surgical 
towel. Supporting the animal by the thorax and lowering the affected hind-limb towards the 
platform of a digital balance, elicits the EPT. As the animal is lowered to the platform, it 
extends the hind-limb, anticipating the contact made by the distal metatarsus and digits. 
The force in grams (g) applied to the digital platform balance is recorded. The same 
procedure is applied to the contra-lateral, unaffected limb. Each EPT test must be repeated 3 
times and the average result is considered. The normal (unaffected limb) EPT (NEPT) and 
experimental EPT (EEPT) values are incorporated into a equation (Equation 1) to derive the 
percentage of functional deficit (Koka & Hadlock, 2001). 
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Percentage motor deficit = [(NEPT – EEPT) / NEPT]*100 
The EPT data, originally measured in grams of weight borne by each hindlimb, is expressed 
as percentage deficit from total bearing weight as determined by the weight borne by the 
unoperated limb. Potential pitfalls of the EPT do exist. It takes a certain training period for 
the tester to become comfortable handling the animals, and this comfort level is critical for 
the animal to behave in a non frightened way. There is also a level of recognition of when 
the animal is bearing its maximum weight, which is critical since the tester is supporting the 
body of the animal at all times. Once this recognition takes place, through training by an 
experienced tester, the examination becomes highly reproducible (Koka & Hadlock, 2001). 
To assess the nociceptive withdrawal reflex (WRL), the hotplate test was modified as described 
by Masters and collaborators (1993). The rat is wrapped in a surgical towel above its waist and 
then positioned to stand with the affected hind paw on a hot plate at 56ºC and with the other 
on a room temperature plate. WRL is defined as the time elapsed from the onset of hotplate 
contact to withdrawal of the hind paw and measured with a stopwatch. Normal rats withdraw 
their paws from the hotplate within 4.3 s or less (Hu et al., 1997). The affected limbs are tested 
3 times, with an interval of 2 min between consecutive tests to prevent sensitization, and the 
three latencies are averaged to obtain a final result (Campbell, 2001). If there is no paw 
withdrawal after 12 s, the heat stimulus is removed to prevent tissue damage, and the animal 
is assigned with the maximal WRL of 12 s (Varejao et al., 2003a). 
5.2 Sciatic functional index (SFI) and static sciatic index (SSI) 
For SFI, animals are tested in a confined walkway measuring 42-cm-long and 8.2-cm-wide, 
with a dark shelter at the end. A white paper is placed on the floor of the rat walking 
corridor. The hind paws of the rats are pressed down onto a finger paint-soaked sponge, 
and they are then allowed to walk down the corridor leaving its hind footprints on the 
paper. Often, several walks are required to obtain clear print marks of both feet. Prior to any 
surgical procedure, all rats are trained to walk in the corridor, and a baseline walking track 
is recorded. Subsequently, walking tracks are recorded pre-operatively (week-0), at weeks 1, 
2, and every two weeks thereafter until week-20. Several measurements are taken from the 
footprints: (I) distance from the heel to the third toe, the print length (PL); (II) distance from 
the first to the fifth toe, the toe spread (TS); and (III) distance from the second to the fourth 
toe, the intermediary toe spread (ITS). The static footprints are obtained at least during four 
occasional rest periods. In the static evaluation (SSI) only the parameters TS and ITS, are 
measured. For both dynamic (SFI) and static assessment (SSI), all measurements are taken 
from the experimental and normal sides. Four steps should be analyzed per rat. Prints for 
measurements should be chosen at the time of walking based on clarity and completeness at 
a point when the rat was walking briskly. The mean distances of three measurements are 
used to calculate the following factors (dynamic and static): 
Toe spread factor (TSF) = (ETS – NTS)/NTS 
Intermediate toe spread factor (ITSF) = (EITS – NITS)/NITS 
Print length factor (PLF) = (EPL – NPL)/NPL 
Where the capital letters E and N indicate injured and non-injured side, respectively. 
The SFI was calculated as described by Bain et al. (1989) (Bain et al., 1989) according to the 
following equation: 
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SFI = -38.3 (EPL – NPL)/NPL + 109.5(ETS-NTS)/NTS + 13.3(EIT-NIT)/NIT – 8.8 = (-38.3 x 
PLF) + (109.5 x TSF) + (13.3 x ITSF) – 8.8  
The SSI is a time-saving and easy technique for accurate functional assessment of peripheral 
nerve regeneration in rats and is calculated using the static factors, not considering the print 
length factor (PL), according to the equation (Bervar, 2000; Meek et al., 2004)  
SSI = [(108.44 x TSF) + (31.85 x ITSF)] - 5.49 
For both SFI and SSI, an index score of 0 is considered normal and an index of -100 indicates 
total impairment. When no footprints are measurable, the index score of -100 is given. In 
each walking track three footprints must be analyzed by a single observer, and the average 
of the measurements are used in SFI calculations. 
5.3 Kinematic analysis 
Locomotion is also of higher functional relevance since it involves integrated function of 
both the motor and sensory systems and their respective components, such as skeletal 
muscles, sensory endings, efferent and afferent nerve fibers and integrative centers within 
the central nervous system. Muscles innervated by sciatic nerve branches include both 
dorsiflexors and plantarflexors and, although in previous studies we focused our kinematic 
analysis only in the stance phase (Amado et al., 2010; Amado et al., 2008; Luis et al., 2008), 
we now prefer to include analysis of the ankle joint motion also during the swing phase in 
order to provide additional information (Joao et al., 2010).  
In our previous studies we analyzed ankle kinematics in the sagittal plane during the stance 
phase of walking either after sciatic nerve transection and repair (Amado et al., 2010; Luis et 
al., 2008) or after sciatic nerve crush (Amado et al., 2008). The two-dimensional (2D) ankle 
motion analysis was conducted during voluntary level walking along a corridor with 
darkened cages at both ends to attract the animals. The lateral walls of the corridor were 
made of Perspex and a high speed video camera (JVC GR-DVL9800, Nex Jersey, USA) was 
placed orthogonally to corridor length in order to record ankle motion during walking. 
Sagittal records of the rat walking were obtained at a frame rate of 100 frames per second 
and images were semi-automatically digitized using marks at reference points of the rat 
hindlimb and foot (see Fig. 4B).  
 
 
Fig. 4. Reflective markers with 2mm diameter were attached to the right hindlimb at bony 
prominences  (from bottom to top): (1) tip of fourth finger, (2) head of fifth metatarsal, (3) 
lateral malleolus, (4) lateral knee joint, (5) trochanter major (A). Tattoo marks at bony 
prominences of the right hindlimb: (1) head of fifth metatarsal, (2) lateral malleolus, (3) 
lateral knee joint (B). 
A B
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The trajectories of the segments leg and hindfoot were obtained through this procedure and 
ankle joint angle was derived by using dot product computation. Ankle kinematics 
parameters proposed by Varejão et al. (2003) were employed in order to assess functional 
recovery after sciatic nerve transection and repair and to compare treatments using our 
tested biomaterials and cellular system. Our ankle joint kinematic analysis generally showed 
profound walking dysfunction in the weeks after sciatic neurotmesis. Changes affected the 
whole stance phase and were best characterized by an inability of the animals to perform the 
normal ankle push off action during the second half of this walking phase (see Fig 5 and 
Fig.6). Profound ankle kinematic changes during the stance phase of walking were also 
evident when taking into account angular velocity data. Uninjured animals show a clear 
ankle angular velocity peak both at the initiation and end of the stance phase. After sciatic 
transection these two peaks are not observed and the stance phase is characterized by a 
rather steady increase in positive   ankle velocity that corresponds to a progressive augment 
in ankle dorsiflexion. This abnormal pattern of ankle motion during the stance phase of 
walking was interpreted as caused by denervation and paralysis of the ankle plantarflexors 
that were unable to actively extend the ankle against the load of the body weight. In sciatic 
nerve transected and repaired animals, the recovery of the normal ankle motion pattern of 
walking is slow and largely incomplete. After 20 weeks of recovery, abnormal ankle motion 
is still noticed after sciatic nerve neurotmesis (Amado et al., 2010; Luis et al., 2008). In our 
recent study (Amado et al., 2010), investigating the role of a collagen membrane with and 
without differentiated N1E-115 cells enwrapped around the transected and end-to-end 
repaired sciatic nerve, the shape of ankle joint motion during the stance phase showed little 
improvements until three months after injury (see Fig 5 and Fig.6). 
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Fig. 5. Kinematics plots in the sagittal plane for the angular position (º) of the ankle as it 
moves through the stance phase, during the healing period of 20 weeks. The mean of each 
group is plotted.  
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Fig. 6. Kinematics plots in the sagittal plane for the angular velocity (º/s) of the ankle as it 
moves through the stance phase, during the healing period of 20 weeks. The mean of each 
group is plotted. 
A progressive improvement in ankle kinematics occurred from this time point up to the end 
of the 20 weeks recovery time. Such improvement consisted mainly in a slight recovery of 
ankle plantarflexion at the end of stance phase and lesser peak dorsiflexion at midstance. 
These changes in ankle kinematics are suggestive of muscle reinnervation and increased 
force generation ability by the ankle pantarflexor muscle group. In this study, ankle 
kinematics data were in general agreement with the results of the EPT and WRL tests. The 
latter tests also demonstrated progressive recovery of motor and sensory function along the 
follow up time that in the case of the WRL test was accelerated beyond the 12 weeks time 
point. As for ankle kinematics, the EPT and WRL results also demonstrated incomplete 
functional recovery in these animals, with slightly better recovery in the end-to-end repair 
group compared to other two groups. However, ankle kinematics must be envisaged merely 
as an indirect measure of muscle function. It should be noticed that walking requires fine 
coordination of limbs motion and definitely quadruped animals have many movement 
strategies to compensate for deficit in one of the hindlimbs. Through plasticity of integrative 
structures, animals may develop adaptive patterns that persist even if significant 
reinnervation takes place. Also, no direct relation exists between more simple tests of muscle 
strength or of sensory function and a complex action such as walking (Varejao et al., 2003b). 
Indeed, ankle kinematics data poses a fundamental question. Does recovery of ankle motion 
during walking signals successful muscle reinnervation and regain of muscle function or 
else is a product of compensatory changes at whole hindlimb level? To answer this question 
satisfactorily, walking analysis has to be improved by extending the analysis to hip and 
knee joints and should be combined with direct measures of muscle activity (Gramsbergen 
et al., 2000a)  and to measures of the force applied to the ground by the walking animal 
(Howard et al., 2000). To better assess hindlimb joint kinematics during walking, we 
recently analyzed hip, knee and ankle joint kinematics during recovery of less severe sciatic 
nerve crush injury, using a more sophisticated motion capture system to track the motion of 
reflective markers attached to the rat hindlimb (unpublished observations) (see Fig. 4A). 
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After this kind of injury, functional recovery is often deemed as complete even on the basis 
of ankle kinematic analysis with only minor walking changes observed after 12 weeks of 
recovery.  However, after 12 weeks of recovery from complete sciatic nerve crush, changes 
in hip and knee kinematics during walking were present, when compared to sham-operated 
control animals. Importantly, such altered hip and knee kinematics were in contrast with 
total reestablishment of the normal pattern of ankle motion in sciatic-crushed animals.  
Individual joint kinematics either in control or nerve-injured animals is characterized by 
high variability, with notable differences between different animals and even from step to 
step (Chang et al., 2009). Such high level of variability, which seems to be an intrinsic 
property of normal quadruped walking, seriously affects the precision of joint kinematic 
measures of functional recovery after nerve injury. Reducing this variability is a challenge 
for efficient use of walking analysis to assess functional recovery. Attempts to overcome this 
limitation include constraining walking velocity by using treadmill walking instead of self-
paced locomotion (Pereira et al., 2006). This, of course, is likely to reduce step-by-step 
variability in joint kinematics but has the disadvantage of requiring expensive equipment 
and limits the possibility of combining kinematic analysis with other data, such as ground 
reaction forces. Other possibilities look at a global, limb-level movement analyses as an 
alternative to individual joints kinematics (Chang et al., 2009; Sabatier et al., 2011). Also, 
systematic changes in the biomechanical and movement control constraints of the locomotor 
task, such as using up- and down-slope walking might also increase the accuracy of walking 
analysis within the context of peripheral nerve research (Sabatier et al., 2011).    
In summary, walking analysis is a promising method to assess functional recovery after 
hindlimb nerve injury. However, in order to provide accurate measures of functional 
recovery, walking analysis after hindlimb peripheral nerve injury will have to evolve from 
simply analyzing ankle kinematics to reach a full biomechanical description of hindlimb 
motion including analysis of hip, knee and ankle joints. Further refinements of walking 
analysis in the field of peripheral nerve research using the rat model will probably include 
the combined use of joint kinematics, ground reaction forces and electromyographical data 
of muscle activity.  
6. Morphological analysis  
It has been recently pointed out that morphological analysis is the far most common method 
for the study of peripheral nerve regeneration (Raimondo et al., 2009). Actually, the 
investigation of nerve morphology can give us important information on various aspects of 
the regeneration processes which relates with nerve function (Geuna et al., 2009).  
Although different types of fixatives can be used for peripheral nerve histology, we fix 
nerve samples in a solution of 2.5% purified glutaraldehyde (Histo-line Laboratories s.r.l., 
Milano, Italy) and 0.5% saccarose (Merck, Darmstadt, Germany) in 0.1M Sörensen 
phosphate buffer, pH 7.4, for 6-8h. Nerves are then washed and stored in 0.1M Sörensen 
phosphate buffer added with 1.5% saccarose at 4-6°C prior to embedding.  Sörensen 
phosphate buffer is made with 56g di-potassium hydrogen phosphate 3-hydrate (K2HPO4-
3H2O) (Fluka, Buchs, Switzerland) and 10.6 g sodium di-hydrogen phosphate 1-hydrate 
(NaH2PO4-H2O) (Merck, Darmstadt, Germany) in 1 litre of doubly-distilled water. Just 
before the embedding, nerves are washed for few minutes in the storage solution and then 
immersed for 2 h in 2% osmium tetroxide (Sigma, St.Louis, MO) in the same buffer solution. 
The specimens are then carefully dehydrated in passages in ethanol and embedded in 
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Glauerts' mixture of resins which is made of equal parts of Araldite M and the Araldite 
Härter, HY 964 (Merck, Darmstad, Germany). At the resin mixture, 2% of accelerator 964, 
DY 064 is added (Merck, Darmstad, Germany). Finally, the plasticizer (0.5% of 
dibutylphthalate) is added to the resin. 
 
 
Fig. 7. Representative high resolution photomicrographs of nerve fibers from normal (A) 
and regenerated (B) rat sciatic nerves after entubulation with collagen nerve guide. Original 
magnification = 1,000x. 
In our laboratory, histomorphometry (stereology) is carried out on toludine-blue-stained 
semi-thin sections (2.5 micron-thick) of nerve samples using a DM4000B microscope 
equipped with a DFC320 digital camera and an IM50 image manager system (Leica 
Microsystems, Wetzlar, Germany). We adopt a final magnification of 6,600x in order to 
enable accurate identification of myelinated nerve fibers (Figure 9). A 2D-disector method, 
(Raimondo et al., 2009) is finally used for estimating the total number of myelinated fibers 
(N), the mean diameter of fiber (D) and axon (d) as well as mean [(D-d)/2] and g-ratio (D/d) 
(see Fig.7). 
7. Synopsis of results and discussion 
Peripheral nerve regeneration can be studied in a number of different experimental models 
based on the use of nerves from both forelimb and hindlimb (Hu et al., 1997). The 
experimental animal model of choice for many researchers remains the rat sciatic nerve. It 
provides an inexpensive source of mammalian nervous tissue of identical genetic stock that 
it is easy to work with and well studied (Geuna et al., 2009) and shows a similar capacity for 
regeneration in rats and sub-humans primates (Johnson et al., 2008). The rat sciatic nerve is a 
widely used model for the evaluation of motor as well as sensory nerve function at the same 
time. One of the most addressed issues in experimental nerve repair research is represented 
by entubulation (Chen et al., 2006). While early studies were more directed towards 
biological material (Kerns et al., 1991) recent studies have focused more on synthetic 
materials that are biodegradable. The majority of natural biomaterials used in clinical 
applications such as hyaluronic acid, collagen, and gelatin are derived from animal sources. 
In spite of thorough purification methods these materials bear the inherent risk of transfer of 
viral and prionic diseases and may cause immunological body reactions (Koka & Hadlock, 
2001; Luis et al., 2007b). Synthetic biomaterials are not associated with these risks (Koka & 
Hadlock, 2001; Luis et al., 2007b). 
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Our group has assessed two types of nerve guides made of a different type of biodegradable 
synthetic biomaterial, PLGA and caprolactone (Neurolac®). Our data showed that both 
types of nerve guides were a mean to help in the growth of axons and didn’t deleteriously 
interfere with the nerve regeneration process. While the information on the effectiveness of 
Neurolac® tubes for allowing nerve regeneration was already provided experimentally (; 
Geuna et al., 2009; Luis et al., 2008) and with patients (Bertleff et al., 2005), the PLGA tubes 
with the polymers proportion of 90 PLA:10 PLG used in that study have never been tested 
in vivo before (Luis et al., 2007b).  Results of the comparative functional assessment showed 
that the differences between the two experimental groups were not significant in terms of 
motor and nociceptive recovery. The EPT proposed by Thalhammer and coworkers (Geuna, 
2005) to evaluate the motor function in rats is used routinely by veterinarian neurologists to 
evaluate the nervous system of small domestic animals. This reflex is initiated by a 
stretching of the spindles in the interosseous muscles and stimulation of sensory receptors 
of the foot (Lundborg, 2002). A steady recover of motor deficit occurred throughout the 20-
week post-surgery period in the group of animals where PLGA and Neurolac® tube-guides 
were used. As expected, the motor recovery in animals of the end-to-end group occurred 
significantly faster and to a larger extent when compared to the entubulation groups. 
Similarly, nociception recovered to a significantly larger extent in the end-to-end group 
compared to both entubulation groups which, on the contrary, did not differ significantly 
between them (Luis et al., 2007b). Interestingly, when the nerve is transected and the 
regenerating axons must bridge a gap, sensory neurons exhibit a faster regenerative pattern 
than motor neurons (Lundborg, 2002). Morphological analysis showed a different pattern of 
biodegradation of the two tubes. In fact, while in the nerves repaired by Neurolac® the 
structure of the polymer was still well preserved at week-20, in the nerves repaired by 
PLGA guides, the polymer was largely substituted by a connective matrix rich in collagen 
fibbers and fibroblasts resembling a normal epineurium. These results may suggest that 
PLGA can be a better biomaterial for fashioning nerve guides since nerves regenerated 
inside it were more similar to a normal nerve than those regenerated inside Neurolac® 
guides, although the results of the motor and sensory functional assessment did not disclose 
significant differences between the two tube-guides and thus both should be considered a 
good substrate for preparing tubular nerve guides. We have also used the rat sciatic nerve 
model for investigating the effects of chitosan type III membranes after neurotmesis 
followed by surgical repair either by direct suture, or autograft or tubulization. 
Morphological results showed that nerve regeneration occurred when the chitosan type III 
tube-guide was used and that, at time of withdrawal, Wallerian degeneration was almost 
completed and substituted by re-growing axons and the accompanying Schwann cells. The 
results obtained with chitosan type III tube-guides were significantly better, in terms of 
functional and morphologic recovery, when compared with PLGA90:10 where the 
regeneration pattern was worse (Simoes et al., 2010). The synergistic effect of a more 
favorable porous microstructure and physicochemical properties (more wettable and higher 
water uptake level) of chitosan type III compared to common chitosan, as well as the 
presence of silica ions, may be responsible for the good results in promoting post-traumatic 
nerve regeneration (Amado et al., 2008) suggesting that this material may not just work as a 
simple mechanical scaffold but instead may work as an inducer of nerve regeneration 
(Amado et al., 2008). The neuroregenerative property of chitosan type III might be explained 
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by a direct stimulation of Schwann cell proliferation, axon elongation and myelination 
(Shirosaki et al., 2005). Yet, the expression of established myelin genes such as PMP22, PO 
and MBP (Pietak et al., 2007) may be influenced by the presence of silica ions which exert an 
effect on several glycoprotein expression (Pietak et al., 2007). Taken together, results of this 
study support the view that hybrid chitosan type III membranes can be a valuable tool for 
fashioning nerve guides aimed to bridge nerve defects. We also investigated the effects on 
nerve regeneration of the employment PLGA90:10 nerve guide tubes covered with N1E-115 
cells in vitro differentiated in the presence of DMSO for 48 hours (Geuna et al., 2001). Results 
showed that both motor and sensory functions improved significantly similarly to what 
occurs in PLGA tubes alone (Luis et al., 2008). Nerve recovery of around 60% was achieved 
by week-20, in both groups, reconstructed with PLGA 90:10 tube-guides with or without the 
cellular system. The pattern of degradation and the degradation products of PLGA90:10 
more acidic than the collagen ones do not seem to influence negatively the degree of nerve 
regeneration during the healing period. On the other hand, the biodegradable non-woven 
structure of PLGA tubes may offer some advantages in terms of microporosity which may 
enhance nerve repair. It is not surprising that recovery was significantly better in the group 
where the gap was reconstructed using the autologous graft since this is still considered the 
gold standard for peripheral nerve regeneration (Matsuyama et al., 2000). The rationale for 
the use of the N1E-115 cells was to take advantages of the properties of these cells as a 
neural-like cellular source of neurotrophic factors (Geuna et al., 2001). 
Although tube guides are a suitable choice for peripheral nerve reconstruction, it is known 
that nerve regeneration and functional recovery are less satisfactory than when nerve repair 
is done by using an end-to-end neurorraphy or when an autologous nerve graft is applied 
(Geuna et al., 2009). For example, the risk of neuroma formation in neurotmesis injury is 
considerable, which is clearly avoided with tube-guide technique. In this sense, enhancing 
the rate of axonal growth might prevent the occurrence of side effects and might turn nerve 
regeneration faster, thus improving functional recovery. Neurotrophic factors play an 
important role in nerve regeneration after injury or disease and it is conceivable that if 
neurotrophic factors are applied in the close vicinity of the injured nerve their healing 
potency is optimized. In spite of these premises and contrary to our initial hypothesis, the 
N1E-115 cells did not facilitate either nerve regeneration or functional recovery and, as far as 
morphometrical parameters are concerned, results showed that the presence of this cellular 
system reduced the number and size of the regenerated fibers. These results suggest that 
this type of nerve guides can partially impair nerve regeneration, at least from a 
morphological point of view (Luis et al., 2008). The impaired axonal regeneration seems to 
be the result of N1E-115 cells surrounding and invading the regenerating nerve, since 
numerous of these cells where seen colonizing the nerve and might have deprived 
regenerated nerve fibers blood supply (Luis et al., 2008). The use of N1E-115 cells did not 
promote nerve healing and their use might even derange the nerve regenerating process. 
Whereas the effects on nerve regeneration were negative, an interesting result of this study 
was the demonstration that the cell delivery system that we have used was effecting in 
enabling long-term colonization of the regenerated nerve by transplanted neural cells. 
Whether the negative effects of using N1E-115 cells as a cellular aid to peripheral neural 
tissue regeneration extends to other types of cells is not known at present and further 
studies are warranted to assess the role of other cellular systems, e.g. mesenchymal stem 
cells, as a foreseeable therapeutic strategy in peripheral nerve regeneration. Our 
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experimental results with this cellular system are also important in the perspective of stem 
cell transplantation employment for improving posttraumatic nerve regeneration with 
patients (Luis et al., 2008). Undoubtedly, great enthusiasm has raised among researchers 
and in the general public about cell-based therapies in regenerative medicine (Geuna et al., 
2009; Thalhammer et al., 1995). There is a widespread opinion that this type of therapy is 
also very safe in comparison to other pharmacological or surgical therapeutic approaches. 
By contrast, recent studies showed that cell-based therapy might be ineffective for 
improving nerve regeneration (Varejao et al., 2003b) or even have negative effects by 
hindering the nerve regeneration process after tubulisation repair. Whereas the choice of the 
cell type to be used for transplantation is certainly very important for the therapeutic 
success, our present results suggest that the paradigm that donor tissues guide transplanted 
stem cells to differentiate in the direction that is useful for the regeneration process it is not 
always true and the possibility that transplanted stem cells choose another differentiation 
line potentially in contrast with the regenerative process should be always taken in 
consideration.  
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